TY - JOUR
T1 - Arrow CorAide Left Ventricular Assist System
T2 - Initial Experience of the Cardio-Thoracic Surgery Center in Pavia
AU - Gazzoli, Fabrizio
AU - Alloni, Alessia
AU - Pagani, Francesco
AU - Pellegrini, Carlo
AU - Longobardi, Antonio
AU - Ricci, Davide
AU - Rinaldi, Mauro
AU - Viganò, Mario
PY - 2007/1
Y1 - 2007/1
N2 - Purpose: The aim of the present study is to describe our preliminary experience with the Arrow CorAide left ventricular assist system (LVAS). Description: The Arrow CorAide LVAS is a small implantable, continuous flow centrifugal pump, with a fully suspended rotating assembly, intended as a bridge to transplant device, bridge to recovery, and for long-term use. Evaluation: Since April 2005 we have implanted the CorAide LVAS in 2 male patients, with a patient follow-up of more than 6 months. Surgical procedures were uneventful, and both patients had an uneventful postoperative course, with fast weaning from mechanical ventilation and inotropic support. No thromboembolic events, infective complication, hemolysis, or mechanical failure occurred. To date, both patients are in New York Heart Association class I. Conclusions: In our initial experience the CorAide LVAS blood pump is nonthrombogenic, nonhemolytic, and easy to implant. Both patients have improved their functional status. Further follow-up is needed to assess long-term results.
AB - Purpose: The aim of the present study is to describe our preliminary experience with the Arrow CorAide left ventricular assist system (LVAS). Description: The Arrow CorAide LVAS is a small implantable, continuous flow centrifugal pump, with a fully suspended rotating assembly, intended as a bridge to transplant device, bridge to recovery, and for long-term use. Evaluation: Since April 2005 we have implanted the CorAide LVAS in 2 male patients, with a patient follow-up of more than 6 months. Surgical procedures were uneventful, and both patients had an uneventful postoperative course, with fast weaning from mechanical ventilation and inotropic support. No thromboembolic events, infective complication, hemolysis, or mechanical failure occurred. To date, both patients are in New York Heart Association class I. Conclusions: In our initial experience the CorAide LVAS blood pump is nonthrombogenic, nonhemolytic, and easy to implant. Both patients have improved their functional status. Further follow-up is needed to assess long-term results.
UR - http://www.scopus.com/inward/record.url?scp=33845510702&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33845510702&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2006.05.026
DO - 10.1016/j.athoracsur.2006.05.026
M3 - Article
C2 - 17184678
AN - SCOPUS:33845510702
VL - 83
SP - 279
EP - 282
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
SN - 0003-4975
IS - 1
ER -